{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:39:53Z","timestamp":1783463993958,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China projects","doi-asserted-by":"crossref","award":["No. 82203612, 82372001"],"award-info":[{"award-number":["No. 82203612, 82372001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Hospitals Authority\u2019s Ascent Plan","award":["No: DFL20241103"],"award-info":[{"award-number":["No: DFL20241103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00259-025-07458-x","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T08:54:52Z","timestamp":1754384092000},"page":"940-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predicting 177Lu-DOTATATE therapy response through immune microenvironment parameters in gastroenteropancreatic neuroendocrine tumors (GEP-NETs)"],"prefix":"10.1007","volume":"53","author":[{"given":"Ziqing","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-3080","authenticated-orcid":false,"given":"Jiangyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"7458_CR1","doi-asserted-by":"publisher","first-page":"1079575","DOI":"10.3389\/fonc.2023.1079575","volume":"13","author":"M Liu","year":"2023","unstructured":"Liu M, Wei L, Liu W, Chen S, Guan M, Zhang Y, et al. Trends in incidence and survival in patients with Gastrointestinal neuroendocrine tumors: A SEER database analysis, 1977\u20132016. Front Oncol. 2023;13:1079575.","journal-title":"Front Oncol"},{"key":"7458_CR2","doi-asserted-by":"publisher","first-page":"624534","DOI":"10.3389\/fphar.2021.624534","volume":"12","author":"X Lu","year":"2021","unstructured":"Lu X, Lu C, Yang Y, Shi X, Wang H, Yang N, et al. Current status and trends in peptide receptor radionuclide therapy in the past 20 years (2000\u20132019): A bibliometric study. Front Pharmacol. 2021;12:624534.","journal-title":"Front Pharmacol"},{"issue":"8","key":"7458_CR3","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s00259-023-06166-8","volume":"50","author":"M Mitjavila","year":"2023","unstructured":"Mitjavila M, Jimenez-Fonseca P, Bell\u00f3 P, Pubul V, Percovich JC, Garcia-Burillo A, et al. Efficacy of [(177)Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study. Eur J Nucl Med Mol Imaging. 2023;50(8):2486\u2013500.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"7458_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00259-019-04601-3","volume":"47","author":"L Bodei","year":"2020","unstructured":"Bodei L, Kidd MS, Singh A, van der Zwan WA, Severi S, Drozdov IA, et al. PRRT neuroendocrine tumor response monitored using Circulating transcript analysis: the netest. Eur J Nucl Med Mol Imaging. 2020;47(4):895\u2013906.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7458_CR5","doi-asserted-by":"crossref","unstructured":"Liberini V, Huellner MW, Grimaldi S, Finessi M, Thuillier P, Muni A, et al. The challenge of evaluating response to peptide receptor radionuclide therapy in gastroenteropancreatic neuroendocrine tumors: the present and the future. Diagnostics (Basel, Switzerland). 2020;10(12): 1083.","DOI":"10.3390\/diagnostics10121083"},{"issue":"9","key":"7458_CR6","doi-asserted-by":"publisher","first-page":"R329","DOI":"10.1530\/ERC-20-0113","volume":"27","author":"TJ Takkenkamp","year":"2020","unstructured":"Takkenkamp TJ, Jalving M, Hoogwater FJH, Walenkamp AME. The immune tumour microenvironment of neuroendocrine tumours and its implications for immune checkpoint inhibitors. Endocrine-related Cancer. 2020;27(9):R329\u201343.","journal-title":"Endocrine-related Cancer"},{"issue":"12","key":"7458_CR7","first-page":"1649","volume":"19","author":"R Bai","year":"2022","unstructured":"Bai R, Li W, Cui J. Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives. Cancer Biology Med. 2022;19(12):1649\u201361.","journal-title":"Cancer Biology Med"},{"issue":"4","key":"7458_CR8","first-page":"344","volume":"3","author":"Y Wu","year":"2013","unstructured":"Wu Y, Pfeifer AK, Myschetzky R, Garbyal RS, Rasmussen P, Knigge U, et al. Induction of Anti-Tumor immune responses by peptide receptor radionuclide therapy with (177)Lu-DOTATATE in a murine model of a human neuroendocrine tumor. Diagnostics (Basel Switzerland). 2013;3(4):344\u201355.","journal-title":"Diagnostics (Basel Switzerland)"},{"issue":"4","key":"7458_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1159\/000517688","volume":"112","author":"L Tanno","year":"2022","unstructured":"Tanno L, Naheed S, Dunbar J, Tod J, Lopez MA, Taylor J, et al. Analysis of immune landscape in pancreatic and ileal neuroendocrine tumours demonstrates an immune cold tumour microenvironment. Neuroendocrinology. 2022;112(4):370\u201383.","journal-title":"Neuroendocrinology"},{"key":"7458_CR10","doi-asserted-by":"publisher","first-page":"654660","DOI":"10.3389\/fimmu.2021.654660","volume":"12","author":"M Wei","year":"2021","unstructured":"Wei M, Xu J, Hua J, Meng Q, Liang C, Liu J, et al. From the immune profile to the immunoscore: signatures for improving postsurgical prognostic prediction of pancreatic neuroendocrine tumors. Front Immunol. 2021;12:654660.","journal-title":"Front Immunol"},{"issue":"4","key":"7458_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R. The Lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385\u201395.","journal-title":"Stat Med"},{"issue":"3","key":"7458_CR12","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P, et al. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022;1(3):e36.","journal-title":"iMeta"},{"issue":"8","key":"7458_CR13","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1158\/1078-0432.CCR-18-1401","volume":"25","author":"L Cai","year":"2019","unstructured":"Cai L, Michelakos T, Deshpande V, Arora KS, Yamada T, Ting DT, et al. Role of Tumor-Associated macrophages in the clinical course of pancreatic neuroendocrine tumors (PanNETs). Clin Cancer Res. 2019;25(8):2644\u201355.","journal-title":"Clin Cancer Res"},{"key":"7458_CR14","doi-asserted-by":"crossref","unstructured":"Deo D, Marchioni M, Rao P. Mesenchymal stem\/stromal cells in organ transplantation. Pharmaceutics. 2022;14(4):791.","DOI":"10.3390\/pharmaceutics14040791"},{"issue":"5","key":"7458_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/v3050586","volume":"3","author":"M F\u00e9vrier","year":"2011","unstructured":"F\u00e9vrier M, Dorgham K, Rebollo A. CD4\u2009+\u2009T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis. Viruses. 2011;3(5):586\u2013612.","journal-title":"Viruses"},{"key":"7458_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers16193410","volume":"16","author":"A Ghebremedhin","year":"2024","unstructured":"Ghebremedhin A, Athavale D, Zhang Y, Yao X, Balch C, Song S. Tumor-Associated macrophages as major immunosuppressive cells in the tumor microenvironment. Cancers. 2024;16:19.","journal-title":"Cancers"},{"issue":"2","key":"7458_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/imm.12507","volume":"146","author":"RA O\u2019Connor","year":"2015","unstructured":"O\u2019Connor RA, Anderton SM. Inflammation-associated genes: risks and benefits to Foxp3\u2009+\u2009regulatory T-cell function. Immunology. 2015;146(2):194\u2013205.","journal-title":"Immunology"},{"issue":"1","key":"7458_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","volume":"6","author":"Z Yan","year":"2025","unstructured":"Yan Z, Wang C, Wu J, Wang J, Ma T. TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives. Mol Biomed. 2025;6(1):27.","journal-title":"Mol Biomed"},{"key":"7458_CR19","doi-asserted-by":"crossref","unstructured":"Venugopal A, Michalczyk A, Khasraw M, Ackland ML. EMT molecular signatures of pancreatic neuroendocrine neoplasms. Int J Mol Sci. 2022;23(21):13645.","DOI":"10.3390\/ijms232113645"},{"issue":"1","key":"7458_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41467-019-14134-w","volume":"11","author":"F Pelon","year":"2020","unstructured":"Pelon F, Bourachot B, Kieffer Y, Magagna I, Mermet-Meillon F, Bonnet I, et al. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms. Nat Commun. 2020;11(1):404.","journal-title":"Nat Commun"},{"key":"7458_CR21","doi-asserted-by":"crossref","unstructured":"Naik M, Al-Nahhas A, Khan SR. Treatment of neuroendocrine neoplasms with radiolabeled peptides-where are we now. Cancers. 2022;14(3):761.","DOI":"10.3390\/cancers14030761"},{"issue":"17","key":"7458_CR22","doi-asserted-by":"publisher","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","volume":"115","author":"E Peranzoni","year":"2018","unstructured":"Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari-Mimoun C, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci USA. 2018;115(17):E4041\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"7458_CR23","first-page":"4283","volume":"11","author":"J Huang","year":"2018","unstructured":"Huang J, Cai X, Ou Y, Zhou Y, Wang Y. Resolution of inflammation in periodontitis: a review. Int J Clin Exp Pathol. 2018;11(9):4283\u201395.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"7458_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14791\/btrt.2022.10.e25","volume":"10","author":"MH Han","year":"2022","unstructured":"Han MH, Kim CH. Current immunotherapeutic approaches for malignant gliomas. Brain Tumor Res Treat. 2022;10(1):1\u201311.","journal-title":"Brain Tumor Res Treat"},{"key":"7458_CR25","doi-asserted-by":"crossref","unstructured":"Men\u00e9ndez V, Sol\u00f3rzano JL, Fern\u00e1ndez S, Montalb\u00e1n C, Garc\u00eda JF. The hodgkin lymphoma immune microenvironment: turning bad news into good. Cancers. 2022;14(5):1360.","DOI":"10.3390\/cancers14051360"},{"issue":"1","key":"7458_CR26","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1038\/s41467-024-47068-z","volume":"15","author":"H Croizer","year":"2024","unstructured":"Croizer H, Mhaidly R, Kieffer Y, Gentric G, Djerroudi L, Leclere R, et al. Deciphering the Spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer. Nat Commun. 2024;15(1):2806.","journal-title":"Nat Commun"},{"issue":"3","key":"7458_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast Cancer. Cancer Cell. 2018;33(3):463\u2013e7910.","journal-title":"Cancer Cell"},{"issue":"12","key":"7458_CR28","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/S1470-2045(21)00572-6","volume":"22","author":"JR Strosberg","year":"2021","unstructured":"Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, et al. (177)Lu-Dotatate plus long-acting octreotide versus high\u2013dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021;22(12):1752\u201363.","journal-title":"Lancet Oncol"},{"issue":"4","key":"7458_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2567.2011.03539.x","volume":"135","author":"CA Lindqvist","year":"2012","unstructured":"Lindqvist CA, Loskog AS. T regulatory cells in B-cell malignancy - tumour support or kiss of death? Immunology. 2012;135(4):255\u201360.","journal-title":"Immunology"},{"key":"7458_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1146\/annurev-immunol-101320-031931","volume":"40","author":"A Roquilly","year":"2022","unstructured":"Roquilly A, Mintern JD, Villadangos JA. Spatiotemporal adaptations of macrophage and dendritic cell development and function. Annu Rev Immunol. 2022;40:525\u201357.","journal-title":"Annu Rev Immunol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07458-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:46:34Z","timestamp":1769222794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07458-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7458"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07458-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures in this retrospective study complied with the Declaration of Helsinki and were approved by the Ethics Committee of Peking University Cancer Hospital (Approval No.: 2017XJS15). Informed consent was waived by the ethics committee due to the retrospective nature of the study using database data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0and informed consent"}},{"value":"The manuscript is approved by all authors for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"We declare that none of our authors have financial or other conflicts of interest that might be construed as influencing the results or interpretation of our study. This study has not been presented anywhere else.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}